Drugs / S-Primaquine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02898779 | May 2017 → Mar 2018 | malaria | University of Mississippi, Oxford | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | (+)-(S)-primaquine | “The clinical formulation of primaquine (PQ) is a mixture of (-)-(R)- and (+)-(S) primaquine enantiomers” PMID 21058417 ↗ Nov 2010 |